Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma

Oncol Res. 2008;17(1):33-41. doi: 10.3727/096504008784046081.

Abstract

RIZ1 isoform, but not RIZ2, is commonly silenced in many types of tumors. In osteosarcoma cells, RIZ1 protein is very abundant. The silencing of YY1 protein, a recent target gene in osteosarcoma cells, reduced the expression of RIZ1 protein. Here we show that RIZ1 overexpression is a transcriptional event documented by Western blot, RT-PCR, and promoter assays. YY1 protein binds and cooperates to positive regulation of the RIZ1 promoter and its presence reduced the dimethyl lysine 9 histone 3 by chromatin immunoprecipitation assays. These results indicate that overexpression of YY1 in osteosarcoma cells plays a key role in positive regulation of RIZ1. The coexpression of RIZ1/YY1 proteins suggests a tandem regulatory mechanism in human osteosarcoma cells and tissues.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Bone Neoplasms / genetics*
  • Cell Line, Tumor
  • Chromatin Immunoprecipitation
  • DNA-Binding Proteins / genetics*
  • Down-Regulation
  • Gene Silencing
  • Histone-Lysine N-Methyltransferase
  • Humans
  • Immunohistochemistry
  • Molecular Sequence Data
  • Nuclear Proteins / genetics*
  • Osteosarcoma / genetics*
  • Promoter Regions, Genetic*
  • Transcription Factors / genetics*
  • YY1 Transcription Factor / genetics
  • YY1 Transcription Factor / physiology*

Substances

  • DNA-Binding Proteins
  • Nuclear Proteins
  • Transcription Factors
  • YY1 Transcription Factor
  • YY1 protein, human
  • Histone-Lysine N-Methyltransferase
  • PRDM2 protein, human